 |
|
|
|
Processing |
|
Welcome Everyone,
The purpose of this area will be to provide information regarding hematopoietic cell processing. As with all areas within
the BMT lab forum, contributions are not based on literature format, but rather on information content. It is th sharing of information/commmunication
that is important to the group, with all contributions considered relevant.
The first contribution to this forum will be on the topic of cryopreservation and also to list possible topics for future discussion.
Posted Documents:
- LABELS USED IN HEMATOPOIETIC PROGENITOR CELL COLLECTION AND PROCESSING
- HEMATOPOIETIC CELL PROCESSING - CRYOPRESERVATION
|
|
top of page
Labels
When preparing for accreditation, an important area of concern is the type
and content of labels used in hematopoietic progenitor cell collection and
processing. There is currently no commercially available label that meets
FACT/AABB standards and many different forms of labels are used across Canada.
The Canadian Blood Services/Ottawa Centre laboratory has developed labels using
FACT guidelines that meet such standards as;
- Unique identifier (tracing component from collection to infusion)
- Proper name of component
- Date and time of collection
- Volume of component
- Volume of additives
- Identity of collection and processing facility
- Expiration date
- Storage conditions
- Autologous/Allogeneic
The labeling system consists of a base label with an attached supplementary
label used for additional specific processing methods. The reason this method
was chosen is because of the many different possible combination of processing
methods currently used in the laboratory and also to accommodate future
processing technology. Also, the labeling system should be clearly defined in a
Standard Operating Procedure (SOP) with examples of completed labels.
Examples:
Base Label
- Bone Marrow - Autologous
- Bone Marrow - Allogeneic
- Peripheral Blood Progenitor Cell - Autologous
- Peripheral Blood Progenitor Cell - Allogeneic
Supplementary Labels (some examples)
- Cryopreserved
- CD34 Enriched
- CD34 Enriched - Cryopreserved
- T-cell Depleted
Our labels are produced using Microsoft word (other facilities have produced
labels using other software) and printed on Avery full sheet labels
81/2 X 11 (Cat#05165) for the base labels and Avery Addressing Labels
4 X 11/3 (Cat#05162) for the supplementary label. These labels can be
printed or photocopied.
To label component;
- supplementary label is affixed to the base label
- base label cut/folded and affixed to a tie tag
- tie tag is attached to component bag using transfer tubing (heat seal loop
to join tie tag and component bag)
Base Label
| |
Supplementary Label
Component Identifier:
CD34 ENRICHED-CRYOPRESERVED Bag
of
Processing Date:
Contains
x106 cells in
mL 5% DMSO, "List
additives" Storage Temperature:<-120OC Label CPL010L11, Version 1.0, Effective Date: 09 April
2001
|
Notes:
- With the Nexell Cryocyte bag containing a label pocket, we also use a
cloth label containing minimal information (unique identifier, donor name,
component type, processing date).
- This labeling system allows viewing/inspection of the component.
I would be interested in hearing about other facilities labeling systems and
the possibility of developing a "Canadian Label" or "BMTlab Group" label to be
commercially manufactured for Canadian collection and processing
facilities.
|
|
|
top of page
HEMATOPOIETIC CELL PROCESSING - CRYOPRESERVATION
Canadian Blood Services / Ottawa Centre Experience
Controlled Rate Cryopreservation - 1985 - 1996
- Standard controlled rate freezing with transfer to liquid nitrogen storage.
"Dump Method" Cryopreservation - 1996 - Present
- Briefly, cryopreservation solution is added to component then transferred directly to liquid nitrogen vapour.
- Cooling Rate: approximately 3 degrees C/minute
- Storage Temperature: < -120 degrees Celcius
REFERENCES
- Galmes A., Besalduch J., Bargay J., et al. Cryopreservation of Hematopoietic Progenitor Cells with 5 Percent Dimethyl Sulfoxide at -80OC Without Rate- controlled Freezing. Transfusion 1996; 36:794-97.
- Stiff, P.J., Koester, A.R., Weidner, M.K., et al. Autologous Bone MarrowTransplantation Using Unfractionated Cells Cryopreserved in Demethylsulfoxideand Hydroxyethyl Starch Without Controlled-Rate Freezing. Blood 1987;70:4:974-78.
- O'Kane-Murphy, B., Jackson, J.D., Dicke, K.A. Analysis of VariationsIn Cryomedium and Methods of Freezing on Human Bone Marrow Stem Cells.In:Advances in Bone Marrow Purging and Processing. Wiley-Liss, 1992; 361-66.
- Rowley, S.D., Bensinger, W.I., Gooley, T.A. et al. Effect of CellConcentration on Bone Marrow and Peripheral Blood Stem CellCryopreservation. Blood 1994;83:9:2731-36.
Cryopreservation Solution
- Pentaspan/HSA/Hank's BSS/DMSO
- (5% final DMSO concentration)
Storage Bags
- Baxter (label pocket)
Storage
- Liquid Nitrogen tank and Ultra Low mechanical freezer
- Transport - liquid nitrogen dry shipper
Labels
- Liquid nitrogen cloth label (label pocket) and tie tag label.
Additional Notes:
- Cryopreservation Validtion - cryopreservation methode must be validated before implemented, usually
consisting of pre and post data (CD34+, nucleated cell counts, viability, current literature).
- Future procedure - controlled rate additional of cryoprotectant (DMSO). (D. Yang - CBS/Edmonton)
|
|
|
Please direct comments or suggestions to either the Administrator, or the Webmaster.
Best viewed with MS Internet Explorer.
|